Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial.

BMC Infect Dis · 2018 · PMC6238264 · PMID 30442095

Europe PMC DOI

hedged sentence

0.0870

closest p · 1.7× alpha

0.0870

boldest claim

The sentences

showed a trendP = 0.087so close (0.05 < p ≤ 0.1)

While patients experiencing acute rejection showed a trend toward an increase in moderate-to-severe IFTA (41% versus 23%; aOR, 2.89; 95% CI, 0.88–9.73; P = 0.087), the effect of polyoma BKV viremia was negligible (29% versus 27%; aOR, 0.60; 95% CI, 0.18–2.07; P = 0.422).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.